Cholesterol-lowering therapy: Is there really a controversy?

被引：7
|
作者：
Jungnickel, PW
机构：
[1] Department of Pharmacy Practice, University of Nebraska, Medical Center, Omaha, NE 68198
来源：
ANNALS OF PHARMACOTHERAPY | 1996年 / 30卷 / 05期
关键词：
D O I：
10.1177/106002809603000520
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：539 / 542
页数：4
相关论文
共 50 条
  • [1] Cholesterol-lowering therapy - Response
    Matsuoka, H
    Tamai, O
    Imaizumi, T
    CIRCULATION, 1997, 96 (10) : 3801 - 3802
  • [2] Cholesterol-lowering therapy for smokers
    Jackson, PR
    LANCET, 2001, 357 (9260): : 960 - 960
  • [3] Pharmacogenomics of cholesterol-lowering therapy
    Schmitz, G
    Langmann, T
    VASCULAR PHARMACOLOGY, 2006, 44 (02) : 75 - 89
  • [4] Appropriate use of cholesterol-lowering therapy
    Falk, Erling
    ATHEROSCLEROSIS, 2017, 262 : 198 - 199
  • [5] Need to individualise cholesterol-lowering therapy
    Luetjohann, Dieter
    Weingaertner, Oliver
    HEART, 2019, 105 (16)
  • [6] The future direction of cholesterol-lowering therapy
    Evans, M
    Roberts, A
    Rees, A
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (06) : 663 - 669
  • [7] Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy
    Schmitz, Gerd
    Schmitz-Madry, Anna
    Ugocsai, Peter
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (02) : 164 - 173
  • [8] Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy
    Schmitz, G
    Drobnik, W
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) : 581 - 589
  • [9] Pleiotropic Effects and Cholesterol-Lowering Therapy
    Shaw, Steven M.
    Fildes, James E.
    Yonan, Nizar
    Williams, Simon G.
    CARDIOLOGY, 2009, 112 (01) : 4 - 12
  • [10] Cholesterol absorption inhibition: A strategy for cholesterol-lowering therapy
    Miettinen, TA
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, 55 (10) : 710 - 716
12345